Opinion|Videos|November 18, 2024
Current Barriers to uACR Testing
Key Takeaways
- Limited awareness and lack of standardized protocols hinder uACR testing, necessitating enhanced provider education and patient awareness initiatives.
- A multimodal approach, including lifestyle changes and pharmacotherapy, is crucial for achieving guideline goals in reducing uACR.
Panelists discuss the current barriers to urine albumin-creatinine ratio (uACR) testing, strategies to address these barriers, the guideline goals for reducing uACR, and the importance of a multimodal approach, as well as how increased awareness of chronic kidney disease (CKD) testing can improve patient outcomes and engage health care providers in promoting testing.
Advertisement
- What are the current barriers to uACR testing?
- How can these barriers to testing be addressed?
- What are the guideline goals for reducing uACR? How much emphasis should be put on a multimodal approach to drive down uACR as much as possible?
- How can increased awareness of CKD testing improve patient outcom
- How can health care providers be engaged in promoting CKD testing?
Newsletter
Join thousands of clinicians staying current on new therapies, trial data, and expert insights—subscribe to HCPLive today.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Metabolic Dysfunction May Explain Sugar-Sweetened Beverage–Gastric Cancer Link, With Andrew Chan, MD, MPH
2
Sugar-Sweetened Beverages Associated With Increased Gastric Cancer Risk, With Andrew Chan, MD, MPH
3
Microneedle Stamp Enters Phase 1 Trial for Peanut Allergy Immunotherapy
4
Ketamine, Psychedelics Share Neuroimmune Signature in TRD
5



































































